Division of University of Havana
Latest From CIMAB SA
India’s Biocon has high expectations for its Herceptin biosimilar, but patient groups are vocal in their criticism of the drug’s price in comparison to Roche’s.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Pharmaceuticals, and Medical Devices – and then categorized by type –Acquisition, Alliance, or Financing.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.